Apollo Hospitals leads the way in treatment of Parkinson's Disease with advanced Deep Brain Stimulation technology


  • Revolutionary technique allows doctors to listen to beta signals in brain, map disease activity

Chennai, 11 April 2023: In an effort to offer hope to patients with Parkinson’s and stay true to its cutting-edge spirit, Apollo Hospitals is offering treatment at a first-of-its-kind Advanced Deep Brain Stimulation Centre in Chennai. The Centre, that is equipped with the latest technology in Parkinson’s treatment, has enabled doctors to provide personalized treatment to patients, resulting in better clinical outcomes and increased patient satisfaction. The Centre has, so far, treated the highest number of patients in Tamil Nadu with these advanced technologies. 

(L to R) Dr RK Venkatachalam, Director, Medical Services , Dr Vijay Shankar, Senior Consultant, Neurologist, Movement Disorders, and Deep Brain Stimulation Specialist, Apollo Hospitals, Dr. Arvind Sukumaran, Senior Consultant, Functional & Epilepsy Neurosurgeon, Apollo Hospitals,  Naveen V, CEO, Apollo Hospitals

The establishment of this Centre is significant as Parkinson's disease can be severely disabling even in its early stages as it impedes the ability to control movement. With conventional Deep Brain Stimulation (DBS), a thin electrode is implanted through minimally invasive keyhole surgery using computer-assisted stereotactic technology, where the electrical fields are projected in all directions equally. This approach has helped several patients achieve clinical benefits. However, the Centre has kept pace with more recent advances in medicine and adopted cutting-edge technology for patients with this condition. 

Dr.Arvind Sukumaran, Senior Consultant Neurosurgeon, Epilepsy & Functional Neurosurgery /DBS specialist, said, “The Percept PC technology adopted at this Centre allows for listening and recording tiny electrical fluctuations called beta band,  in the target area.  Sensight is an advanced electrode that allows doctors to listen to the beta band signals in the brain and gain crucial information about disease activity. This allows us to identify the direction of maximum beta band activity, and direct the electricity in that direction, while assessing the clinical benefits.” This approach results in the delivery of precise electrical current with limited adverse effects, resulting in targeted treatment of the disease.

Dr. Vijay Shankar, Senior Consultant, Neurologist, Movement Disorders, and Deep Brain Stimulation Specialist, Apollo Hospitals, said, "We are proud to be at the forefront of advancing treatment for Parkinson's disease. With the adoption of this technology, we have helped patients make significant progress and report improvements in their quality of life.  Our patients have reported improved limb movement and other functional outcomes. This technology not just marks a giant leap in the treatment of movement disorders but will also help patients connect better within their communities and lead happier lives.”

****

Recent Posts

𝘎𝘌𝘔 𝘏𝘰𝘴𝘱𝘪𝘵𝘢𝘭 & 𝘚𝘳𝘪 𝘙𝘢𝘮𝘢𝘬𝘳𝘪𝘴𝘩𝘯𝘢 𝘏𝘰𝘴𝘱𝘪𝘵𝘢𝘭 𝘚𝘶𝘤𝘤𝘦𝘴𝘴𝘧𝘶𝘭𝘭𝘺 𝘱𝘦𝘳𝘧𝘰𝘳𝘮 𝘐𝘯𝘥𝘪𝘢’𝘴 𝘍𝘪𝘳𝘴𝘵 "𝘐𝘯𝘵𝘦𝘳-𝘏𝘰𝘴𝘱𝘪𝘵𝘢𝘭 𝘚𝘸𝘢𝘱 𝘓𝘪𝘷𝘦𝘳 𝘛𝘳𝘢𝘯𝘴𝘱𝘭𝘢𝘯𝘵" 𝘪𝘯 𝘊𝘰𝘪𝘮𝘣𝘢𝘵𝘰𝘳𝘦

𝘋𝘢𝘪𝘮𝘭𝘦𝘳 𝘓𝘢𝘶𝘯𝘤𝘩𝘦𝘴 𝘈𝘭𝘭 𝘕𝘦𝘸 𝘉𝘩𝘢𝘳𝘢𝘵 𝘉𝘦𝘯𝘻 𝘏𝘟 & 𝘛𝘖𝘙𝘘𝘚𝘏𝘐𝘍𝘛 𝘊𝘰𝘯𝘴𝘵𝘳𝘶𝘤𝘵𝘪𝘰𝘯 & 𝘔𝘪𝘯𝘪𝘯𝘨 𝘊𝘰𝘮𝘮𝘦𝘳𝘤𝘪𝘢𝘭 𝘛𝘳𝘶𝘤𝘬𝘴 𝘵𝘰 𝘗𝘰𝘸𝘦𝘳 𝘐𝘯𝘥𝘪𝘢'𝘴 𝘐𝘯𝘧𝘳𝘢𝘴𝘵𝘳𝘶𝘤𝘵𝘶𝘳𝘦 𝘉𝘰𝘰𝘮

𝘌𝘢𝘳𝘵𝘩𝘦𝘯 𝘚𝘱𝘢𝘤𝘦𝘴 & 𝘚𝘶𝘨𝘢𝘭 𝘎𝘳𝘰𝘶𝘱 𝘓𝘢𝘶𝘯𝘤𝘩𝘦𝘴 𝘪𝘵𝘴 𝘧𝘭𝘢𝘨𝘴𝘩𝘪𝘱 𝘎𝘢𝘵𝘦𝘥 𝘝𝘪𝘭𝘭𝘢 𝘗𝘭𝘰𝘵𝘴 𝘢𝘵 𝘒𝘦𝘭𝘢𝘮𝘣𝘢𝘬𝘬𝘢𝘮; 𝘉𝘶𝘪𝘭𝘥𝘪𝘯𝘨 𝘢 𝘓𝘦𝘨𝘢𝘤𝘺 𝘪𝘯 𝘔𝘰𝘥𝘦𝘳𝘯 𝘙𝘦𝘢𝘭 𝘌𝘴𝘵𝘢𝘵𝘦